Sandoz Canada announced on June 19th the finalization of its collaboration with Tilray and is now able to enter the medical cannabis field. The company has worked with Tilray to distribute their eight Sandoz and Tilray co-branded products.
Sandoz utilizes Tilray’s Access to Cannabis for Medical Purposes Regulations (ACMPR) license to create cannabis capsules and edible oils.
The company will not venture into the recreational markets of Canada and does not have intentions to expand into the combustible cannabis market.
The Sandoz medical cannabis products will be available to over 270,000 Canadian patients.